US3723032062
US3723032062
Genmab A/S
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 3.720.000.000 | 3.121.000.000 | 19.2% |
| Cost of Revenue | 238.000.000 | 143.000.000 | 66.4% |
| Gross Profit | 3.482.000.000 | 2.978.000.000 | 16.9% |
| 2.232.000.000 | 1.963.000.000 | 13.7% | |
| Operating Income | 1.250.000.000 | 1.015.000.000 | 23.2% |
| Pretax Income | 1.204.000.000 | 1.326.000.000 | 9.2% |
| Net Income Common Stockholders | 963.000.000 | 1.133.000.000 | 15.0% |
| -- | -- | -- | |
| -- | -- | -- |